Aclarion, Inc. ACON Stock Forecast
AI-powered price prediction and analysis for Aclarion, Inc. · Alpha · vs marketSwitch to Total
See ACON's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Aclarion, Inc.
Aclarion, Inc. (ACON) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry.
Latest News
Where ACON sits on the market map
Services-Medical Laboratories Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| ACON Aclarion, Inc. | ▶ | N/A | – |
| NTRA Natera, Inc. | ▶ | $57.03B | – |
| DGX Quest Diagnostics Inc | ▼ | $25.44B | 24.0x |
| LH Labcorp Holdings Inc. | ▶ | $25.44B | 25.4x |
| GH Guardant Health, Inc. | ▲ | $21.75B | – |
| CAI Caris Life Sciences, Inc. | ▲ | $8.35B | – |
| GRAL Grail, Inc. | ▲ | $6.27B | – |
| RDNT Radnet, Inc. | ▼ | $5.63B | – |
| BLLN Billiontoone, Inc. | ▲ | $4.46B | – |
| VCYT Veracyte, Inc. | ▲ | $3.47B | 30.3x |
| CDNA Caredx, Inc. | ▲ | $3.38B | 30.5x |
| CELC Celcuity Inc. | ▶ | $3.09B | – |
| FTRE Fortrea Holdings Inc. | ▲ | $1.99B | – |
| PSNL Personalis, Inc. | ▶ | $1.69B | – |
| LMRI Lumexa Imaging Holdings, Inc. | ▲ | $1.02B | – |
| CSTL Castle Biosciences Inc | ▲ | $1.00B | – |
| FLGT Fulgent Genetics, Inc. | ▲ | $579M | – |
| BDSX Biodesix Inc | ▲ | $264M | – |
| XGN Exagen Inc. | ▲ | $205M | – |
| SERA Sera Prognostics, Inc. | ▼ | $80M | – |
| CFOR Capforce Inc. | ▼ | $49M | – |
| AMS American Shared Hospital Services | ▲ | $8M | – |
| LUDG Ludwig Enterprises, Inc. | ▼ | $840K | – |
| FCHS First Choice Healthcare Solutions, … | ▶ | $300K | – |
| ADVB Advanced Biomed Inc. | ▶ | N/A | – |
| BGLC Bionexus Gene Lab Corp | ▼ | N/A | – |
| BNR Burning Rock Biotech Ltd | ▲ | N/A | – |
| FRNM Freenome, Inc. | ▼ | N/A | – |
| MDXH Mdxhealth Sa | ▼ | N/A | – |
| RNLXY Renalytix Plc | ▶ | N/A | – |
FAQ
Is Aclarion, Inc. a good stock to buy?
Our AI analyzes Aclarion, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Aclarion, Inc. predictions?
A per-ticker accuracy statistic for ACON is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Aclarion, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Aclarion, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.